Connection

Co-Authors

This is a "connection" page, showing publications co-authored by TANYA MOSELEY and BEATRIZ ELENA ADRADA.
Connection Strength

2.707
  1. MRI-guided Breast Biopsy Case-based Review: Essential Techniques and Approaches to Challenging Cases. Radiographics. 2022 Mar-Apr; 42(2):E46-E47.
    View in: PubMed
    Score: 0.819
  2. Multimodality Imaging of Benign and Malignant Diseases of the Nipple-Areolar Complex. Radiographics. 2024 04; 44(4):e230113.
    View in: PubMed
    Score: 0.238
  3. Triple-Negative Breast Cancer: Histopathologic Features, Genomics, and Treatment. Radiographics. 2023 10; 43(10):e230034.
    View in: PubMed
    Score: 0.230
  4. Bracketing with Multiple Radioactive Seeds to Achieve Negative Margins in Breast Conservation Surgery: Multiple Seeds in Breast Surgery. Clin Breast Cancer. 2022 02; 22(2):e158-e166.
    View in: PubMed
    Score: 0.195
  5. Early ultrasound evaluation identifies excellent responders to neoadjuvant systemic therapy among patients with triple-negative breast cancer. Cancer. 2021 08 15; 127(16):2880-2887.
    View in: PubMed
    Score: 0.194
  6. Molecular Breast Imaging-guided Percutaneous Biopsy of Breast Lesions: A New Frontier on Breast Intervention. J Breast Imaging. 2020 Sep-Oct; 2(5):484-491.
    View in: PubMed
    Score: 0.185
  7. Stereoscopic interpretation of low-dose breast tomosynthesis projection images. J Digit Imaging. 2014 Apr; 27(2):248-54.
    View in: PubMed
    Score: 0.119
  8. Multiparametric MRI-based radiomic models for early prediction of response to neoadjuvant systemic therapy in triple-negative breast cancer. Sci Rep. 2024 07 12; 14(1):16073.
    View in: PubMed
    Score: 0.061
  9. Diffusion Tensor Imaging for Characterizing Changes in Triple-Negative Breast Cancer During Neoadjuvant Systemic Therapy. J Magn Reson Imaging. 2024 Oct; 60(4):1367-1376.
    View in: PubMed
    Score: 0.059
  10. Predicting pathological complete response to neoadjuvant systemic therapy for triple-negative breast cancers using deep learning on multiparametric MRIs. Annu Int Conf IEEE Eng Med Biol Soc. 2023 07; 2023:1-4.
    View in: PubMed
    Score: 0.056
  11. Review of the Sonographic Features of Interpectoral (Rotter) Lymph Nodes in Breast Cancer Staging. Ultrasound Q. 2023 Jun 01; 39(2):69-73.
    View in: PubMed
    Score: 0.056
  12. Prediction of pathologic complete response to neoadjuvant systemic therapy in triple negative breast cancer using deep learning on multiparametric MRI. Sci Rep. 2023 01 20; 13(1):1171.
    View in: PubMed
    Score: 0.055
  13. Challenging Contrast-Enhanced Mammography-Guided Biopsies: Practical Approach Using Real-Time Multimodality Imaging and a Proposed Procedural Algorithm. AJR Am J Roentgenol. 2023 04; 220(4):512-523.
    View in: PubMed
    Score: 0.054
  14. Quantitative Apparent Diffusion Coefficients From Peritumoral Regions as Early Predictors of Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer. J Magn Reson Imaging. 2022 12; 56(6):1901-1909.
    View in: PubMed
    Score: 0.052
  15. Reply to "Additional References Relevant to Preoperative Breast Lesion Localization Techniques". AJR Am J Roentgenol. 2022 03; 218(3):562.
    View in: PubMed
    Score: 0.051
  16. The Challenging Image-Guided Preoperative Breast Localization: A Modality-Based Approach. AJR Am J Roentgenol. 2022 03; 218(3):423-434.
    View in: PubMed
    Score: 0.050
  17. Detection of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. AJR Am J Roentgenol. 2011 Oct; 197(4):W761-8.
    View in: PubMed
    Score: 0.050
  18. Tumor necrosis by pretreatment breast MRI: association with neoadjuvant systemic therapy (NAST) response in triple-negative breast cancer (TNBC). Breast Cancer Res Treat. 2021 Jan; 185(1):1-12.
    View in: PubMed
    Score: 0.046
  19. A Clinical Feasibility Trial for Identification of Exceptional Responders in Whom Breast Cancer Surgery Can Be Eliminated Following Neoadjuvant Systemic Therapy. Ann Surg. 2018 05; 267(5):946-951.
    View in: PubMed
    Score: 0.039
  20. Biopsy Feasibility Trial for Breast Cancer Pathologic Complete Response Detection after Neoadjuvant Chemotherapy: Imaging Assessment and Correlation Endpoints. Ann Surg Oncol. 2018 Jul; 25(7):1953-1960.
    View in: PubMed
    Score: 0.039
  21. Identification of Patients With Documented Pathologic Complete Response in the Breast After Neoadjuvant Chemotherapy for Omission of Axillary Surgery. JAMA Surg. 2017 07 01; 152(7):665-670.
    View in: PubMed
    Score: 0.037
  22. Conspicuity of microcalcifications on digital screening mammograms using varying degrees of monitor zooming. Acad Radiol. 2009 Dec; 16(12):1509-17.
    View in: PubMed
    Score: 0.022
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.